Rheos
is a biopharmaceutical company that develops novel immune cell therapies for the treatment of cancer and inflammatory diseases... Read moreRheos
is a biopharmaceutical company that develops novel immune cell therapies for the treatment of cancer and inflammatory diseases... Read more
News
Jul 20, 2022
Business Wire
Press Release: Rheos : Rheos Medicines Receives FDA "Study May Proceed" Letter to Initiate Phase 1 Clinical Study Under its Investigational New Drug Application for RHX-317 for Treatment of Autoimmune and Inflammatory Diseases
May 12, 2022
Business Wire
Press Release: Rheos : Rheos Medicines CSO Dania Rabah to Deliver Keynote Address at AAPS National Biotechnology Conference
May 08, 2022
Acrofan
Rheos: Rheos Medicines Announces Publication of New Data to Support Targeting MALT1 to Treat Autoimmune and Inflammatory Diseases
Apr 14, 2022
Citybizlist
Rheos: Rheos Medicines Appoints Katerina Leftheris, Ph.D., as SVP and Nabil Uddin, Pharm.D., as VP
Apr 14, 2022
FirstWord Pharma
Rheos: Rheos Medicines Announces New Scientific Advisory Board Members
Dec 13, 2021
Business Wire
Press Release: Rheos Medicines : Rheos Medicines Presents New Data Supporting MALT1 Inhibition as Novel Strategy for Precision Medicine-Based Approach to Treating Chronic Graft-Versus-Host Disease
Dec 13, 2021
firstword pharma
Rheos Medicines: Rheos Medicines Presents New Data Supporting MALT1 Inhibition as Novel Strategy for Precision Medicine-Based Approach to Treating Chronic Graft-Versus-Host Disease
Dec 09, 2021
Business Wire
Press Release: Rheos Medicines : Rheos Medicines to Participate in the 2021 RBC Capital Markets Healthcare Private Company Conference
Nov 04, 2021
MarketScreener
Rheos Medicines: Rheos Medicines to Present Data at ASH 2021 for MALT1 Inhibition for Treatment of Graft-Versus-Host Disease
Oct 27, 2021
Business Wire
Press Release: Rheos Medicines : Rheos Medicines Forms Research Collaboration With CRYOSTEM to Evaluate MALT1Targeted Therapeutics for Graft-versus-Host-Disease
Rheos Competitors
1
2
3
4
5
6
7
8
9
10